Virtual care for women with hormonal, metabolic and reproductive health needs.
GV (Google Ventures)
Activity from announced rounds
GV invests in technology and life-science companies, including AI applications, developer tools, cybersecurity, computing infrastructure and healthcare.
Its AI interests span the stack: new computing systems and inference infrastructure, tools for developers, software for professional workflows and applications in drug discovery and patient care. This gives both infrastructure founders and application builders a route to a specialist investment team.
GV developed the design sprint, a five-day process that takes a business question through problem definition, prototyping and customer testing. Its published sprint materials help teams test demand and product decisions before committing to a full launch.
- Rounds participated in
- 10
- Confirmed lead rounds
- 0 9 roles undisclosed
- New companies
- 10 First participation on record · 0 follow-on
- Funding in participating rounds
- $3B 10 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
10 in this selectionDevelops fungal genome-derived therapeutics for organ transplant rejection
Develops hormonal and non-hormonal male contraceptives for men and couples globally
Offers an FDA-cleared AI-powered glucose monitoring system for weight management and metabolic health
Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas
Develops technology and services for clinical research.
Provides AI platform for healthcare finance
Provides accessible, insurance-covered services in all 50 states for women's healthcare
Provides AI-powered medical search engine for clinicians
Provides AI-native due diligence for life sciences dealmaking